ETON PHARMACEUTICALS INC. - COMMON STOCK
17.34
02-5月-25 15:45:00
15 分の遅延
株式
+0.37
+2.18%
本日の幅
16.85 - 17.49
ISIN
N/A
ソース
NASDAQ
-
Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
03 5 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
16 3 2023 15:01:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
15 3 2023 05:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
07 3 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
11 1 2023 05:50:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
10 11 2022 15:05:01 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
02 11 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference
18 10 2022 05:50:00 提供 Nasdaq GlobeNewswire
-
13 9 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
30 8 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results
11 8 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
02 8 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)
18 7 2022 06:05:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Sale of Hospital Products
24 6 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2022 Financial Results
12 5 2022 15:02:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
03 5 2022 15:02:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer
11 4 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection
11 4 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2021 Financial Results
16 3 2022 15:02:00 提供 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Fourth Quarter 2021 Financial Results on Wednesday, March 16, 2022
08 3 2022 07:00:01 提供 Nasdaq GlobeNewswire